InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Wednesday, 04/28/2010 10:47:14 AM

Wednesday, April 28, 2010 10:47:14 AM

Post# of 66
9:01AM Endologix announces publication of consolidated long-term anatomical fixation clinical trial results (ELGX) 4.70 : Co announces the publication of consolidated results from its prospective, multicenter clinical trials of the Company's Powerlink stent graft for the endovascular repair of abdominal aortic aneurysms using an anatomical fixation technique. The trial results demonstrate no aneurysm ruptures, no conversions to open repair, no device migrations, no stent fractures, no graft fatigue, no junctional endoleaks, no transgraft endoleaks, and 100% freedom from aneurysm-related mortality for up to five years post-implant. In addition, core lab evaluations found a low rate of limb occlusion, with significantly reduced or stable aneurysm sacs in 95% and 93% of patients at one year and five years, respectively.


surf's up......crikey



Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.